Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
27.81
+0.16 (0.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Anbio Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,221 | 1,320 | - | - | - | - |
| Enterprise Value | 1,209 | 1,306 | - | - | - | - |
| Last Close Price | 27.81 | 30.07 | - | - | - | - |
| PE Ratio | 189.67 | 206.11 | - | - | - | - |
| PS Ratio | 141.16 | 152.64 | - | - | - | - |
| PB Ratio | 40.48 | 43.77 | - | - | - | - |
| P/TBV Ratio | 40.48 | 43.77 | - | - | - | - |
| EV/Sales Ratio | 139.79 | 151.08 | - | - | - | - |
| EV/EBIT Ratio | 209.56 | 226.50 | - | - | - | - |
| Net Debt / Equity Ratio | -0.39 | -0.39 | -0.68 | -0.65 | -0.69 | -1.65 |
| Asset Turnover | 0.35 | 0.35 | 0.47 | 0.45 | 2.50 | - |
| Quick Ratio | 177.13 | 177.13 | 7.41 | 11.65 | 6.14 | 2.06 |
| Current Ratio | 344.31 | 344.31 | 10.71 | 15.86 | 9.88 | 2.07 |
| Return on Equity (ROE) | 27.05% | 27.05% | 14.83% | 16.47% | 132.75% | - |
| Return on Assets (ROA) | 14.66% | 14.66% | 7.18% | 8.23% | 67.52% | - |
| Return on Capital Employed (ROCE) | 19.10% | 19.10% | 11.60% | 13.20% | 81.30% | 96.80% |
| Earnings Yield | 0.52% | 0.48% | - | - | - | - |
| Buyback Yield / Dilution | -3.26% | -3.26% | -97.30% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.